Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis
Crossref DOI link: https://doi.org/10.1007/s40263-014-0207-x
Published Online: 2014-10-19
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xinke
Hay, Joel W.
Niu, Xiaoli
Text and Data Mining valid from 2014-10-19